Chiasma Reports Second Quarter 2017 Results

WALTHAM, Mass., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a clinical-stage biopharmaceutical ...

Chiasma Reports Second Quarter 2017 Results

WALTHAM, Mass., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a clinical-stage biopharmaceutical ...

Ascendis Pharma A/S Announces Upcoming Investor Presentations

COPENHAGEN, Denmark, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical ...

Ascendis Pharma A/S Announces Upcoming Investor Presentations

COPENHAGEN, Denmark, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical ...

Ascendis Pharma A/S Announces Second Quarter 2017 Financial Results Conference Call on August 18

COPENHAGEN, Denmark, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical ...

Ascendis Pharma A/S Announces Second Quarter 2017 Financial Results Conference Call on August 18

COPENHAGEN, Denmark, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical ...

Versartis Reports Second Quarter 2017 Financial Results

MENLO PARK, Calif., July 27, 2017 (GLOBE NEWSWIRE) -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused ...